Trial Reporting in Immuno-Oncology (TRIO): an @ASCO - @sitcancer Statement [Oct 19, 2018] @LiaTsimberidou et al. #JITC https://t.co/Svq9I4ykzS #ImmunoOnc #ClinicalTrials #irAE
23,102 followers
23,102 followers
Trial Reporting in Immuno-Oncology (TRIO): an @ASCO - @sitcancer Statement [Oct 19, 2018] @LiaTsimberidou et al. #JITC https://t.co/Svq9I4ykzS #ImmunoOnc #ClinicalTrials #irAE
3,372 followers
RT @jitcancer: #ICYMI A joint statement from @sitcancer and @ASCO presents recommendations that are intended to improve the reporting of IO…
8,098 followers
#ICYMI A joint statement from @sitcancer and @ASCO presents recommendations that are intended to improve the reporting of IO #clinicaltrials and provide more complete evidence on the relative benefits and risks of an IO therapeutic approach. https://t.co/E